Skip to main content
Erschienen in: International Urology and Nephrology 3/2019

22.01.2019 | Urology - Original Paper

Whole mount histopathological correlation with prostate MRI in Grade I and II prostatectomy patients

verfasst von: Michael Wang, Nafiseh Janaki, Christina Buzzy, Laura Bukavina, Amr Mahran, Kirtishri Mishra, Gregory MacLennan, Lee Ponsky

Erschienen in: International Urology and Nephrology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in detection and surveillance of prostate cancer. However, the co-localization of lower grade lesions between mpMRI and histopathologic specimen has not been well established.

Objective

We aim to determine the factors on final histopathological exam that correlate to tumor visibility for Grade I and II disease on mpMRI.

Methods

Fifty-five patients who underwent radical prostatectomy from July 2014 to June 2016 were analyzed for the study. Of the sample of 55 patients, 18 were found to have Gleason score (GS) of 3 + 3 or 3 + 4 disease, and then were re-reviewed and annotated by a pathologist. Lesion diameter, area, and distance from the prostate capsule were measured. The annotated lesions were co-localized to the MRI report.

Results

Of the 184 lesions identified on the whole mount histopathologic slides, 106 (57.6%), 62 (33.7%), 14 (7.6%), and 2 (1.1%) of the lesions had a GS of 3 + 3, 3 + 4, 4 + 3, and 4 + 4, respectively. On analysis, 27.3% (24/88) of GS 6 (< 1.5 cm in size), and 88.9% (16/18) of GS 6 (> 1.5 cm in size) were identified (p < 0.001). Additionally, when assessing lesion proximity to the prostatic capsule, 46.1% (41/89) of lesions closer (≤ 0.05 cm), and 30.5% (29/95) of lesions further (> 0.05 cm) from the capsule were visualized.

Conclusion

Lesion diameter, area, and capsule proximity correlated with MRI visibility. Further studies are encouraged to validate the findings of our study.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Le JD, Tan N, Shkolyar E et al (2015) Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol 67:569–576CrossRefPubMed Le JD, Tan N, Shkolyar E et al (2015) Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol 67:569–576CrossRefPubMed
2.
Zurück zum Zitat Russo F, Regge D, Armando E et al (2016) Detection of prostate cancer index lesions with multiparametric magnetic resonance imaging (mp-MRI) using whole-mount histological sections as the reference standard. BJU Int 118:84–94CrossRefPubMed Russo F, Regge D, Armando E et al (2016) Detection of prostate cancer index lesions with multiparametric magnetic resonance imaging (mp-MRI) using whole-mount histological sections as the reference standard. BJU Int 118:84–94CrossRefPubMed
3.
Zurück zum Zitat Bratan F, Niaf E, Melodelima C et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019–2029CrossRefPubMed Bratan F, Niaf E, Melodelima C et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019–2029CrossRefPubMed
4.
Zurück zum Zitat Becker AS, Cornelius A, Reiner CS et al (2017) Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer. Eur J Radiol 94:58–63CrossRefPubMed Becker AS, Cornelius A, Reiner CS et al (2017) Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer. Eur J Radiol 94:58–63CrossRefPubMed
5.
Zurück zum Zitat Barentsz JO, Weinreb JC, Verma S et al (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69:41–49CrossRefPubMed Barentsz JO, Weinreb JC, Verma S et al (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69:41–49CrossRefPubMed
6.
Zurück zum Zitat Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging—reporting and data system: 2015, Version 2. Eur Urol 69:16–40CrossRefPubMed Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging—reporting and data system: 2015, Version 2. Eur Urol 69:16–40CrossRefPubMed
7.
Zurück zum Zitat Liu W, Laitinen S, Khan S et al (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15:559–565CrossRefPubMedPubMedCentral Liu W, Laitinen S, Khan S et al (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15:559–565CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Turkbey B, Brown AM, Sankineni S et al (2016) Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin 66:326–336CrossRefPubMed Turkbey B, Brown AM, Sankineni S et al (2016) Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin 66:326–336CrossRefPubMed
9.
Zurück zum Zitat Baco E, Ukimura O, Rud E et al (2015) Magnetic resonance imaging–transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67:787–794CrossRefPubMed Baco E, Ukimura O, Rud E et al (2015) Magnetic resonance imaging–transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67:787–794CrossRefPubMed
10.
Zurück zum Zitat Rud E, Klotz D, Rennesund K et al: Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114: E32–E42 Rud E, Klotz D, Rennesund K et al: Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114: E32–E42
11.
Zurück zum Zitat Delongchamps NB, Lefèvre A, Bouazza N et al (2015) Detection of significant prostate cancer with magnetic resonance targeted biopsies—should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? J Urol 193:1198–1204CrossRefPubMed Delongchamps NB, Lefèvre A, Bouazza N et al (2015) Detection of significant prostate cancer with magnetic resonance targeted biopsies—should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? J Urol 193:1198–1204CrossRefPubMed
12.
Zurück zum Zitat Rosenkrantz AB, Verma S, Turkbey B (2015) Prostate cancer: top places where tumors hide on multiparametric MRI. Am J Roentgenol 204:W449–W456CrossRef Rosenkrantz AB, Verma S, Turkbey B (2015) Prostate cancer: top places where tumors hide on multiparametric MRI. Am J Roentgenol 204:W449–W456CrossRef
13.
Zurück zum Zitat Rosenkrantz AB, Taneja SS (2015) Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer. Acad Radiol 22:1000–1006CrossRefPubMed Rosenkrantz AB, Taneja SS (2015) Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer. Acad Radiol 22:1000–1006CrossRefPubMed
14.
Zurück zum Zitat Panebianco V, Barchetti F, Barentsz J et al (2015) Pitfalls in interpreting mp-MRI of the prostate: a pictorial review with pathologic correlation. Insights Imaging 6:611–630CrossRefPubMedPubMedCentral Panebianco V, Barchetti F, Barentsz J et al (2015) Pitfalls in interpreting mp-MRI of the prostate: a pictorial review with pathologic correlation. Insights Imaging 6:611–630CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat de Gorski A, Rouprêt M, Peyronnet B et al (2015) Accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinically significant prostate cancer in enlarged compared to smaller prostates. J Urol 194:669–673CrossRefPubMed de Gorski A, Rouprêt M, Peyronnet B et al (2015) Accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinically significant prostate cancer in enlarged compared to smaller prostates. J Urol 194:669–673CrossRefPubMed
16.
Zurück zum Zitat Giannarini G, Crestani A, Rossanese M et al (2017) Multiparametric magnetic resonance imaging targeted biopsy for early detection of prostate cancer: All That Glitters Is Not Gold! Eur Urol 71:904–906CrossRefPubMed Giannarini G, Crestani A, Rossanese M et al (2017) Multiparametric magnetic resonance imaging targeted biopsy for early detection of prostate cancer: All That Glitters Is Not Gold! Eur Urol 71:904–906CrossRefPubMed
17.
Zurück zum Zitat Walton Diaz A, Hoang AN, Turkbey B et al (2013) Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol 190:2020–2025CrossRefPubMed Walton Diaz A, Hoang AN, Turkbey B et al (2013) Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol 190:2020–2025CrossRefPubMed
18.
Zurück zum Zitat Zhu X, Albertsen PC, Andriole GL et al (2012) Risk-based prostate cancer screening. Eur Urol 61:652–661CrossRefPubMed Zhu X, Albertsen PC, Andriole GL et al (2012) Risk-based prostate cancer screening. Eur Urol 61:652–661CrossRefPubMed
19.
Zurück zum Zitat Briganti A, Chun FK-H, Suardi N et al (2007) Prostate volume and adverse prostate cancer features: fact not artifact. Eur J Cancer 43:2669–2677CrossRefPubMed Briganti A, Chun FK-H, Suardi N et al (2007) Prostate volume and adverse prostate cancer features: fact not artifact. Eur J Cancer 43:2669–2677CrossRefPubMed
20.
Zurück zum Zitat Freedland SJ, Isaacs WB, Platz EA et al (2005) Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 23:7546–7554CrossRefPubMed Freedland SJ, Isaacs WB, Platz EA et al (2005) Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 23:7546–7554CrossRefPubMed
21.
Zurück zum Zitat Chen ME, Troncoso P, Johnston D et al (1999) Prostate cancer detection: relationship to prostate size. Urology 53:764–768CrossRefPubMed Chen ME, Troncoso P, Johnston D et al (1999) Prostate cancer detection: relationship to prostate size. Urology 53:764–768CrossRefPubMed
22.
Zurück zum Zitat Rosenkrantz AB, Lim RP, Haghighi M et al (2013) Comparison of interreader reproducibility of the prostate imaging reporting and data system and Likert scales for evaluation of multiparametric prostate MRI. Am J Roentgenol 201:W612–W618CrossRef Rosenkrantz AB, Lim RP, Haghighi M et al (2013) Comparison of interreader reproducibility of the prostate imaging reporting and data system and Likert scales for evaluation of multiparametric prostate MRI. Am J Roentgenol 201:W612–W618CrossRef
Metadaten
Titel
Whole mount histopathological correlation with prostate MRI in Grade I and II prostatectomy patients
verfasst von
Michael Wang
Nafiseh Janaki
Christina Buzzy
Laura Bukavina
Amr Mahran
Kirtishri Mishra
Gregory MacLennan
Lee Ponsky
Publikationsdatum
22.01.2019
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02083-8

Weitere Artikel der Ausgabe 3/2019

International Urology and Nephrology 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.